Publication | Open Access

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial

Bone DiseaseZoledronic AcidBone LossBone HealthClinical TrialsMedicineRadiation OncologyOsteoporosisOrthopaedic SurgeryHealth Sciences